新型冠状病毒感染相关性肾损伤

doi:10.6040/j.issn.1671-7554.0.2020.206

摘要/Abstract

摘要： 新型冠状病毒是已知的继SARS、MERS之后第3种高致病性冠状病毒,给我国乃至全球带来巨大的公共卫生问题。自武汉疫情爆发至今,人类对新型冠状病毒的认知不断完善,但是对于肾脏损伤的关注和认知仍有诸多不足。肾脏是新型冠状病毒感染的主要靶点之一,病毒入侵诱发的细胞因子风暴、炎症细胞浸润和病毒直接攻击肾脏均可以引起肾脏损伤,并且临床证据也表明肾脏损伤比例较高,血肌酐或尿素氮升高、急性肾损伤、蛋白尿、血尿均是住院患者死亡的独立危险因素,持续性肾脏替代治疗(CRRT)的及早介入能够改善重症患者预后。肾脏损伤对于疫情的筛查、防疫、患者病情判断及预后评估意义重大。

关键词: 新型冠状病毒, 肾脏, 肾损伤, 炎症因子风暴, 持续性肾脏替代治疗, 防疫

Abstract: Coronavirus disease 2019(COVID-19)is the third knowing high pathogenic coronavirus after SARS and MERS. It challenged the public health in China and even all over the world. Since the breakout of COVID-19 in Wuhan, the recognition of human to this coronavirus has been improving, however, the recognition and attention of kidney injury due to COVID-19 are remain insufficient. Kidney is one of the main target infected by COVID-19. The infection of COVID-19 induced cytokine storm, inflammatory cell infiltration, and direct attack on kidney would cause kidney injury. High kidney injury ratio has been showed in clinical evidence. The makers of renal injury including AKI(elevated serum creatinine and urea nitrogen), proteinuria and hematuria are independent risk factors for in-hospital death. The early intervention of continuous renal replacement therapy(CRRT)would improve the outcome of severe patients. Kidney injury has great roles in screening of the infected patients, epidemic prevention, the evaluation of disease condition and prognosis.

Key words: Coronavirus disease 2019, Kidney, Kidney injury, Cytokine storm, Continuous renal replacement therapy, Epidemic prevention

中图分类号:

R563.1

胡昭,王强. 新型冠状病毒感染相关性肾损伤[J]. 山东大学学报 (医学版), 2020, 58(3): 26-31.

HU Zhao, WANG Qiang. Coronavirus disease 2019 infection associated kidney injury[J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 26-31.

参考文献 29

[1]	Giwa A, Desai A. Novel coronavirus COVID-19: an overview for emergency clinicians[J]. Emerg Med Pract, 2020, 22(2 Suppl 2): 1-21.
[2]	Liu YL, Sun WW, Li J, et al. Clinical features and progression of acute respiratory distress syndrome in coronavirus disease 2019[J]. MedRxiv Preprint, 2020. doi: https://doi.org/10.1101/2020.02.17.20024166.
[3]	Xu HY, Hou KK, Xu H, et al. Acute myocardial injury of patients with coronavirus disease 2019[J]. MedRxiv Preprint, 2020. doi:https://doi.org/10.1101/2020.03.05.20031591.
[4]	Diao B, Feng ZQ, Wang CH, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection[J]. MedRxiv Preprint, 2020. doi: https://doi.org/10.1101/2020.03.04.2003-1120.
[5]	Fan ZY, Chen LP, Li J, et al. Clinical features of COVID-19 related liver damage[J]. MedRxiv Preprint, 2020. doi: https://doi.org/10.1101/2020.02.26.20026971.
[6]	Liang WC, Feng ZJ, Rao ST, et al. Diarrhea may be underestimated: a missing link in 2019 novel coronavirus[J]. MedRxiv Preprint, 2020. doi: https://doi.org/10.1101/2020.02.03.20020289.
[7]	Liu FR, Long X, Zou WB, et al. Highly ACE2 expression in pancreas may cause pancreas damage after SARS-CoV-2 infection[J]. MedRxiv Preprint, 2020. doi: https://doi.org/10.1101/2020.02.28.20029181.
[8]	Mao L, Wang MD, Chen SH, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study[J]. MedRxiv Preprint, 2020. doi: https://doi.org/10.1101/2020.02.22.20026500.
[9]	Fan CB, Li K, Ding YH, et al. ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection[J]. MedRxiv Preprint, 2020. doi: https://doi.org/10.1101/2020.02.12.20022418.
[10]	Yan RH, Zhang YY, Li YN, et al. Structure of dimeric full-length human ACE2 in complex with B0AT1[J].BioRxiv.doi: https://doi.org/10.1101/2020.02.17.951848.
[11]	Wrapp D, Wang N, Corbett KS, et al.Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation[J]. Science, 2020. doi: 10.1126/science.abb2507.
[12]	Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology[J]. Seminin Immunopathol, 2017, 39(5): 529-539.
[13]	Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J].Lancet, 2020, 395(10223):497-506.
[14]	Wan SX, Yi QJ, Fan SB, et al. Characteristics of lymphocyte subsets and cytokines inperipheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia(NCP)[J]. MedRxivPreprint, 2020.doi: https://doi.org/10.1101/2020.02.10.20021832.
[15]	Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome[J]. Lancet Respir Med, 2020. doi: 10.1016/S2213-2600(20)30076-X.
[16]	Tian SF, Hu WD, Niu L, et al. Pulmonary pathology of early phase SARS-COV-2 pneumonia[J]. Preprints, 2020. doi:10.20944/preprints202002.0220.v1.
[17]	Guery B, Poissy J, el Mansouf L, et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission[J]. Lancet, 2013, 381(9885): 2265-2272.
[18]	Zhao X, Chu H, Wong BH, et al. Activation of C-type lectin receptor and(RIG)-I-like receptors contributes to proinflammatory response in Middle East respiratory syndrome coronavirus-infected macrophages[J]. J Infect Dis, 2020, 221(4): 647-659.
[19]	Ding Y, Wang H, Shen H, et al. The clinical pathology of severe acute respiratory syndrome(SARS): a report from China[J]. J Pathol, 2003, 200(3): 282-289.
[20]	Li Z, Wu M, Guo J, et al. Caution on kidney dysfunctions of 2019-nCoV patients[J]. MedRxiv Preprint, 2020. doi: https://doi.org/10.1101/2020.02.08.20021212.
[21]	Cheng YC, Luo R, Wang K, et al. Kidney impairment is associated with in-hospital death of COVID-19 patients [J]. MedRxiv Preprint, 2020. doi: https://doi.org/10.1101/2020.02.18.20023242.
[22]	Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China[J]. N Engl J Med, 2020. doi: 10.1056/NEJMoa2002032.
[23]	Wang LW, Li X, Chen H, et al. SARS-CoV-2 infection does not significantly cause acute renal injury: an analysis of 116 hospitalized patients with COVID-19 in a single hospital, Wuhan, China[J]. MedRxiv Preprint, 2020. doi: https://doi.org/10.1101/2020.02.19.20025288.
[24]	Yeo C, Kaushal S, Yeo D. Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? [J]. Lancet Gastroenterol Hepatol, 2020, pii: S2468-1253(20)30048-0. doi: 10.1016/S2468-1253(20)30048-0.
[25]	Peng L, Liu J, Xu WX, et al. 2019 novel coronavirus can be detected in urine, blood, anal swabs and oropharyngeal swabs samples[J]. MedRxiv, 2020. doi: https: //doi.org/10.1101/2020.02.21.20026179
[26]	Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury[J]. Lancet, 2020, 395(10223): 473-475.
[27]	Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies [J]. Biosci Trends, 2020. doi: 10.5582/bst.2020.01047.
[28]	Yang YZ, Liu LJ, Shi SF, et al. Effects of hydroxychloroquine on proteinuria in immunoglobulin A nephropathy[J]. Am J Nephrol, 2018, 47(3): 145-152.
[29]	Gao R, Wu W, Wen Y, et al. Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy[J]. Int Urol Nephrol, 2017, 49(7): 1233-1241.

相关文章 15

[1]	吴逸南葛志明李方贺红姜虹张运. 自发性高血压大鼠肾脏血管紧张素转换酶2的表达[J]. 山东大学学报(医学版), 2209, 47(6): 5-.
[2]	武琪琪,成淼淼,肖晓燕. 多模态模型在肾脏病领域的应用[J]. 山东大学学报 (医学版), 2025, 63(10): 117-124.
[3]	张学宇,张学海,孙文青,刘晗,姜金波,刘寒,李远,陈晓梅. 重症新型冠状病毒肺炎伴侵袭性肺曲霉病及反复致命性消化道出血1例[J]. 山东大学学报 (医学版), 2024, 62(7): 56-61.
[4]	刁玉洁,林琳,李文瑄,王洲洋,江蓓,胡迎迎,刘广义. NPR预测ANCA相关血管炎不良肾脏预后及其协同多因素优化模型[J]. 山东大学学报 (医学版), 2024, 62(2): 60-68.
[5]	王玉淼,崔晓霈,张红雨. 高龄老年新型冠状病毒肺炎患者应用抗凝治疗的短期疗效和安全性[J]. 山东大学学报 (医学版), 2024, 62(12): 21-31.
[6]	吴飞,李清丽,肖振卫. 孟德尔随机化探究细胞因子与慢性肾脏病的因果关系[J]. 山东大学学报 (医学版), 2024, 62(11): 85-95.
[7]	高玉杰,龙启福,胡英,许玉珍,王茹,永胜. 生物信息学鉴定低氧诱导小鼠肾脏线粒体损伤的Hub基因及其作用机制[J]. 山东大学学报 (医学版), 2023, 61(9): 57-68.
[8]	王骏仁,李道卫,王星光,姜淑娟. 吸入布地奈德/福莫特罗治疗新型冠状病毒感染后咳嗽的疗效[J]. 山东大学学报 (医学版), 2023, 61(8): 50-53.
[9]	邵长秀,贺青卿,庄晓璇,周鹏,李小磊,岳涛,徐婧,李陈钰,郭浩男,庄大勇. 甲状旁腺全切加微量腺体自体移植术治疗109例肾性继发性甲状旁腺功能亢进的长期疗效[J]. 山东大学学报 (医学版), 2023, 61(4): 42-48.
[10]	高丽鹤,任婧婧,李岩,李强,马万山,李焕杰,陈振,欧兰香,张绍明,朱之炜,丁兴龙,李红霞,王岩,张忠法,汪运山. 新型冠状病毒中和抗体酶联免疫检测试剂盒的制备及应用[J]. 山东大学学报 (医学版), 2023, 61(4): 77-85.
[11]	张忆朦,孙巧玲,杨向东. 过敏性紫癜合并视神经脊髓炎谱系疾病1例[J]. 山东大学学报 (医学版), 2023, 61(2): 137-140.
[12]	王园园,孙云. 合并新型冠状病毒肺炎的维持性血液透析患者死亡危险因素[J]. 山东大学学报 (医学版), 2023, 61(11): 68-73.
[13]	宋宜耘,于慧,高兆丽,李宪花. 基于SIRT1/PGC-1α通路探讨葡萄籽原花青素提取物对糖尿病肾脏疾病大鼠的保护作用[J]. 山东大学学报 (医学版), 2023, 61(1): 1-9.
[14]	刘敏,张玉超,马小莉,刘昕宇,孙露,左丹,刘元涛. 孤核受体NR4A1在H₂O₂诱导小鼠肾脏足细胞损伤中的作用[J]. 山东大学学报 (医学版), 2022, 60(5): 16-21.
[15]	王洲洋,江蓓,李宪花,甄军晖,杨向东,胡昭,刘广义,裴斐. 感染性心内膜炎、急性肾损伤伴PR3-ANCA阳性患者1例报道[J]. 山东大学学报 (医学版), 2022, 60(2): 60-64.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed